STRS Ohio’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-500
| Closed | -$50K | – | 2068 |
|
|
2023
Q2 | $50K | Buy |
+500
| New | +$47.3K | ﹤0.01% | 1807 |
|
|
2021
Q4 | – | Sell |
-1,400
| Closed | -$140K | – | 2325 |
|
|
2021
Q3 | $140K | Buy |
1,400
+100
| +8% | +$11.7K | ﹤0.01% | 1873 |
|
|
2021
Q2 | $183K | Buy |
+1,300
| New | +$147K | ﹤0.01% | 1838 |
|
|
2020
Q3 | – | Sell |
-4,068
| Closed | -$634K | – | 2306 |
|
|
2020
Q2 | $634K | Buy |
4,068
+258
| +7% | +$39.2K | ﹤0.01% | 1135 |
|
|
2020
Q1 | $549K | Hold |
3,810
| – | – | ﹤0.01% | 1061 |
|
|
2019
Q4 | $778K | Buy |
3,810
+510
| +15% | +$93K | ﹤0.01% | 1092 |
|
|
2019
Q3 | $264K | Sell |
3,300
-800
| -20% | -$67.9K | ﹤0.01% | 1571 |
|
|
2019
Q2 | $386K | Buy |
4,100
+300
| +8% | +$25.9K | ﹤0.01% | 1434 |
|
|
2019
Q1 | $324K | Buy |
+3,800
| New | +$315K | ﹤0.01% | 1507 |
|
|
2017
Q4 | – | Sell |
-21,800
| Closed | -$677K | – | 1949 |
|
|
2017
Q3 | $677K | Hold |
21,800
| – | – | ﹤0.01% | 1207 |
|
|
2017
Q2 | $689K | Buy |
21,800
+15,000
| +221% | +$369K | ﹤0.01% | 1115 |
|
|
2017
Q1 | $154K | Hold |
6,800
| – | – | ﹤0.01% | 1566 |
|
|
2016
Q4 | $148K | Hold |
6,800
| – | – | ﹤0.01% | 1590 |
|
|
2016
Q3 | $179K | Buy |
6,800
+4,900
| +258% | +$97.2K | ﹤0.01% | 1572 |
|
|
2016
Q2 | $37K | Buy |
+1,900
| New | +$36.9K | ﹤0.01% | 1815 |
|
Other funds holding RETA
STRS Ohio's RETA Position: Q3 2023 in Review
STRS Ohio sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 500 shares — an estimated $50K sold.
STRS Ohio first reported a position in RETA in Q2 2016 and held it in 15 quarters. The position peaked at $778K in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- STRS Ohio reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- STRS Ohio sold 500 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $50K.
- STRS Ohio first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2016 and held it in 15 quarters.
- STRS Ohio's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $778K in Q4 2019.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on STRS Ohio's 13F filing for Q3 2023, filed 26 Oct 2023.